Legal Representation
Attorney
Melissa W. Woo-Allen
USPTO Deadlines
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 14, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 14, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 10, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 6, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 6, 2021 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Aug 6, 2021 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 14, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 12, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 12, 2021 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 12, 2021 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 7, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 5, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 5, 2020 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 5, 2020 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 8, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 7, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 7, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 17, 2020 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Mar 16, 2020 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Mar 16, 2020 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Mar 16, 2020 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Mar 9, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 9, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 6, 2020 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 6, 2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 11, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 11, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 22, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 9, 2019 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 6, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 22, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 22, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 22, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 22, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 22, 2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 19, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 19, 2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 19, 2019 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 19, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 19, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 17, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 2, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of glaucoma and ocular hypertension
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the wording "ONCE-DAILY" above the term "ROCKLATAN" in lower case block letters with "ROCK" in a darker shade than "LATAN" and in between four curved bands, which create the impression of parentheses, two curved bands before "ROCKLATAN" and two curved bands after "ROCKLATAN" with the words "(NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%" beneath the word "ROCKLATAN".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ONCE-DAILY" AND "(NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005%"